478 related articles for article (PubMed ID: 15265983)
21. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
22. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
23. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
24. p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Bargonetti J; Chicas A; White D; Prives C
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):935-49. PubMed ID: 9449526
[TBL] [Abstract][Full Text] [Related]
25. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
Moberg KH; Tyndall WA; Hall DJ
J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
[TBL] [Abstract][Full Text] [Related]
26. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
27. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
[TBL] [Abstract][Full Text] [Related]
28. Sp1 is a key regulator of the PDGF beta-receptor transcription.
Molander C; Hackzell A; Ohta M; Izumi H; Funa K
Mol Biol Rep; 2001; 28(4):223-33. PubMed ID: 12153142
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
Heckman CA; Mehew JW; Boxer LM
Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of SV40 large T antigen induced apoptosis by small T antigen.
Kolzau T; Hansen RS; Zahra D; Reddel RR; Braithwaite AW
Oncogene; 1999 Sep; 18(40):5598-603. PubMed ID: 10523837
[TBL] [Abstract][Full Text] [Related]
33. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.
Jun DY; Park HS; Lee JY; Baek JY; Park HK; Fukui K; Kim YH
Gene; 2008 May; 414(1-2):106-14. PubMed ID: 18378410
[TBL] [Abstract][Full Text] [Related]
34. Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
Mao DY; Barsyte-Lovejoy D; Ho CS; Watson JD; Stojanova A; Penn LZ
Nucleic Acids Res; 2004; 32(11):3462-8. PubMed ID: 15226411
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
37. Suppression of platelet-derived growth factor alpha- and beta-receptor mRNA levels in human fibroblasts by SV40 T/t antigen.
Wang JL; Nistér M; Bongcam-Rudloff E; Pontén J; Westermark B
J Cell Physiol; 1996 Jan; 166(1):12-21. PubMed ID: 8557760
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human EDF-1 minimal promoter: involvement of NFY and Sp1 in the regulation of basal transcription.
Bolognese F; Pitarque-Martì M; Lo Cicero V; Mantovani R; Maier JA
Gene; 2006 Jun; 374():87-95. PubMed ID: 16567061
[TBL] [Abstract][Full Text] [Related]
39. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
[TBL] [Abstract][Full Text] [Related]
40. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
Dkhissi F; Raynal S; Jullien P; Lawrence DA
Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
